Combined treatment with endobronchial Watanabe spigot and N ‐butyl‐2‐cyanoacrylate for refractory pneumothorax in COVID‐19

Coronavirus disease 2019 (COVID‐19) causes pneumothorax or mediastinal emphysema in approximately 1% of patients. According to the British Thoracic Society guidelines, the next treatment option for patients with persistent pneumothorax despite chest drainage is pleurodesis or surgery. In fact, there...

Descripción completa

Detalles Bibliográficos
Autores principales: Morita, Chie, Kitamura, Atsushi, Okafuji, Kohei, Ro, Shosei, Imai, Ryosuke, Shirasaki, Kasumi, Watanabe, Yu, Nishimura, Naoki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2022
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918464/
https://www.ncbi.nlm.nih.gov/pubmed/35309960
http://dx.doi.org/10.1002/rcr2.923

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8918464/
https://www.ncbi.nlm.nih.gov/pubmed/35309960
http://dx.doi.org/10.1002/rcr2.923

Ejemplares similares